Caitong International Asset Management Co., LTD Relay Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 63 shares of RLAY stock, worth $246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 63
-0.0%
Holding current value
$246
Previous $260,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
206Shares Held
159MCall Options Held
100KPut Options Held
26.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$109 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$58.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$41.3 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$35.1 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$31.6 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $471M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...